Vaxcyte (PCVX) Interest & Investment Income (2019 - 2026)
Vaxcyte (PCVX) reported Interest & Investment Income of $26.6 million for Q1 2026, down 19.2% year-over-year from $32.9 million in Q1 2025, and up 0.6% quarter-over-quarter from $26.5 million in Q4 2025.
Vaxcyte (PCVX) Interest & Investment Income (2019 - 2026) Analysis & Trends
Vaxcyte (PCVX) has 8 years of Interest & Investment Income data on file, last reported at $26.6 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $26.6 million, down 19.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $113.4 million (down 6.49% YoY), and the FY2025 annual result was $119.7 million, up 8.84% from the prior year.
- Interest & Investment Income advanced to $26.6 million in Q1 2026 per PCVX's latest filing, from $26.5 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $36.5 million in Q4 2024 and troughed at $134000.0 in Q1 2022.
- A 5-year average of $19.3 million and a median of $21.7 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income jumped 7655.97% in 2023, then slipped 27.45% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $6.6 million in 2022, then jumped by 164.86% to $17.6 million in 2023, then surged by 107.53% to $36.5 million in 2024, then slipped by 27.45% to $26.5 million in 2025, then increased by 0.6% to $26.6 million in 2026.
- Business Quant data shows PCVX's Interest & Investment Income at $26.6 million in Q1 2026, $26.5 million in Q4 2025, and $29.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - | 26.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.61 Mn |
| Dec 31, 2025 | 26.45 Mn |
| Sep 30, 2025 | 29.26 Mn |
| Jun 30, 2025 | 31.07 Mn |
| Mar 31, 2025 | 32.94 Mn |
| Dec 31, 2024 | 36.46 Mn |
| Sep 30, 2024 | 28.06 Mn |
| Jun 30, 2024 | 23.81 Mn |
| Mar 31, 2024 | 21.67 Mn |
| Dec 31, 2023 | 17.57 Mn |
| Sep 30, 2023 | 18.50 Mn |
| Jun 30, 2023 | 16.45 Mn |
| Mar 31, 2023 | 10.39 Mn |
| Dec 31, 2022 | 6.63 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 399,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 99,000.00 |
| Sep 30, 2021 | 90,000.00 |
| Jun 30, 2021 | 93,000.00 |